Literature DB >> 8737945

Enzyme-linked immunosorbent assay, complement fixation test and immunoelectroprecipitation test in the diagnosis of Mycoplasma pneumoniae infections--comparative analysis.

W Rastawicki1, M Jagielski.   

Abstract

Agreement of the results of determining antibodies against M. pneumoniae was evaluated by ELISA, complement fixation test (CFT) and immunoelectroprecipitation test (IEPT) in serum samples from 685 persons including 571 patients with respiratory tract infections and 114 clinically healthy subjects. Assuming the CF test to be the reference test, a very high correlation exceeding 0.95 was found, on the basis of the calculated correlation coefficient, between the results of the CF and IEP tests and the CFT and ELISA for all immunoglobulin classes. The highest sensitivity (92.3%) was displayed by the ELISA in relation to the CF test when determining mycoplasmal antibodies of Ig M and Ig A+G+M classes and a slightly lower sensitivity by the IEPT and ELISA when determining Ig G (83% and 82.1%, respectively). The lowest sensitivity was displayed by the ELISA when determining mycoplasmal antibodies of the Ig A class (53.4%). The specificity of both tests was high and exceeded 92%. The highest agreement of CFT and ELISA was obtained when detecting mycoplasmal antibodies in a diagnostically significant titre in the M and A+G+M immunoglobulin classes (> 92%) while the lowest agreement, although statistically significant, was obtained when detecting Ig A antibodies (74.7%).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737945     DOI: 10.1016/s0934-8840(96)80124-1

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  2 in total

1.  Occurrence of serologically verified Mycoplasma pneumoniae infections in Poland in 1970-1995.

Authors:  W Rastawicki; S Kałuzewski; M Jagielski
Journal:  Eur J Epidemiol       Date:  1998-01       Impact factor: 8.082

2.  Aetiology and clinical presentation of mild community-acquired bacterial pneumonia.

Authors:  B Beović; B Bonac; D Kese; T Avsic-Zupanc; S Kreft; G Lesnicar; J Gorisek-Rebersek; L Rezar; S Letonja
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-09-12       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.